M
Medicus Pharma Ltd. (MDCX)
NCM – Real Time Price. Currency in USD
0.32
-0.02 (-5.26%)
At close: May 12, 2026, 4:00 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
0.32
-0.02 (-5.26%)
At close: May 12, 2026, 4:00 PM EDT
Revenue breakdown data has not been calculated yet.
No Data
There are no news for this stock.
Company's cash reserves $6.4M significantly exceed its total debt $4.0M, ensuring strong financial flexibility
Total current assets $7.1M are just enough to cover Total current liabilities $7.3M, indicating tight liquidity
Debt-to-equity ratio (146.8) far exceeds the industry average, reflecting over-leverage
Interest coverage ratio (-28.6x) is dangerously low, suggesting debt repayment risks
Negative free cash flow -$4.6M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 0.99 | 1.97 | 6.0 | |
| Quick ratio | 0.99 | 1.37 | 6.0 | |
| Debt to Equity | N/A | -7.73 | 1.0 | |
| Debt to Assets | 0.54 | 0.29 | 4.0 | |
| Interest coverage | -28.56 | 36.83 | 1.0 | |
| Weighted average score | 3.6 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | N/A | N/A | N/A | N/A |
| Operating Income | -752K | -4M | -8M | -18M | -18M |
| Net Income | -1M | -4M | -8M | -25M | -25M |
| EBITDA | -752K | -4M | -8M | -18M | -18M |
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Gross margin % | N/A | 67.05 | 1.0 | |
| Operating margin % | N/A | 0.14 | 1.0 | |
| Net margin % | N/A | 9.34 | 1.0 | |
| EBITDA margin % | N/A | 19.90 | 1.0 | |
| Cash flow margin % | N/A | 21.79 | 1.0 | |
| Weighted average score | 1.0 | |||
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | 54.28 | 5.5 |
| Next quarter | N/A | 58.74 | 5.5 |
| Current year | N/A | 78.68 | 5.5 |
| Next year | N/A | 29.6 | 5.5 |
| Weighted average score | 5.5 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | 49.42 | 43.75 | 7.08 | 8.8 |
| Y/Y | 999 | -260.87 | -349.99 | -110.72 | 3.3 |
| 3y average | 999 | -173.72 | -50.42 | -180.02 | 3.3 |
| 5y average | N/A | N/A | N/A | N/A | 1.0 |
| Weighted average score | 4.1 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |